PDMR Notification RSU Vesting
No summary for this filing – the full text is below.
Select text to share a quote on X · sign in to keep highlights & notes in your PRTC notes
PDMR Notifications
PureTech Health plc (Nasdaq: PRTC, LSE: PRTC) ("PureTech" or the "Company"), a clinical-stage biotherapeutics company dedicated to giving life to new classes of medicine to change the lives of patients with devastating diseases, announces that awards of restricted share units ("RSUs") granted by PureTech on 21 July 2021 to certain directors and other persons discharging managerial responsibilities ("PDMRs") pursuant to its Performance Share Plan ("PSP") vested on 4 March 2024 following satisfaction of performance conditions measured over the three year period to 31 December 2023.
Each PDMR received vested ordinary shares (after deduction of shares for payroll taxes) on 5 March 2024. The market price per ordinary share in the Company used to calculate the amount payable to the PDMRs and the amount of shares to be issued to PDMRs was 200 pence, being the average closing price of the Company's shares over the three-trading day period immediately preceding the settlement, and the exchange rate used to calculate the cash payment and amount of share settlement was £1: $1.26.
PDMR Notification
| 1 | Details of the person discharging managerial responsibilities/person closely associated | |
| a) | Name | Daphne Zohar Bharatt Chowrira Eric Elenko |
| 2 | Reason for the notification | |
| a) | Position/status | Daphne Zohar - Chief Executive Officer Bharatt Chowrira - President and Chief Business, Financial and Operating Officer Eric Elenko - Chief Innovation and Strategy Officer |
| b) | Initial notification/Amendment | Initial Notification |
| a) | Name | PureTech Health plc |
| b) | LEI | 213800LVPDNO2Z9T9I39 |
| c) | Price(s) and volume(s) | Recipient Price Amount Daphne Zohar 0.01 GBP 148,482 ordinary shares Bharatt Chowrira 0.01 GBP 59,287 ordinary shares Eric Elenko 0.01 GBP 51,591 ordinary shares |
| e) | Date of the transaction | 5 March 2024 |
| f) | Place of the transaction | London Stock Exchange (XLON) |
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.